EP300/CREBBP Regulation: Metabolic Cofactors vs. Histone Acetyltransferase Inhibitors #3720801 (License: Personal Use)

The image depicts a balance scale with EP300/CREBBP positioned at the fulcrum, symbolizing its central regulatory role in histone acetylation. On the left pan, stacked components-Acetyl-CoA, PANK4, PANK3, and SLC5A6-represent metabolic pathways supplying acetyl groups and coenzymes essential for enzymatic activity; on the right, HATi (histone acetyltransferase inhibitor) represents pharmacological suppression. This metaphor highlights the dynamic equilibrium controlling epigenetic gene expression through substrate availability versus inhibition.

Used in molecular biology, epigenetics, or cancer therapeutics webpages to explain how cellular metabolism intersects with epigenetic regulation. Matches user intent seeking mechanistic understanding of EP300/CREBBP modulation in disease contexts like leukemia or solid tumors.